Snowflake Shares Surge 36 After Earnings Beat and 6 Billion AWS Cloud Expansion Plan Vickers Top Insider Picks Report Released for May 27 2026 Bernstein Maintains Outperform Rating on UnitedHealth Amid PBM Transparency Developments Q4 Earnings Roundup Sun Pharma Info Edge and Eicher Motors Post Profit Gains Hindalco Torrent Pharma See Declines Retail Investors Gain Direct Access to SpaceX IPO Through Major Brokerage Platforms SpaceX Successfully Launches Starship Test Flight After Initial Scrubbed Attempt ABM Q1 2026 Earnings EPS Misses Estimates as Stock Slips Slightly Youdao DAO Q1 2026 Earnings EPS Misses Estimates but Stock Surges Over 12 JD Q1 2026 Earnings EPS Misses Estimates Shares Decline on Weak Profitability HSTM Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher OMER Q1 2026 Earnings Significant EPS Beat Amid Pipeline Progress ATXG Q1 2025 Earnings Reported Loss Per Share of 025 Amidst Limited Financial Disclosure CocaCola KO Stock Climbs 182 as Beverage Giant Approaches Key Resistance Donegal Group DGICA Declines 16 as Stock Tests Key Support Levels Crocs Inc CROX Holds Steady Near Midpoint as Footwear Sector Watches for Breakout Cohen Steers ClosedEnd Opportunity Fund FOF Nears Support After Minor Decline Cathay General Bancorp CATY Declines Sharply as Bearish Volume Pressures Support Level Ukraines AIEnabled Martian Drones Disrupt Russian Supply Lines Raising Defense Sector Implications PAX Q1 2026 Earnings EPS Misses Estimates Shares Decline Heritage Financial Corporation HFWA Modestly Rises as Bank Sector Stability Supports Price Action Dow Inc DOW GARP Investment Potential Strengthens Amid Transform to Outperform Strategy Source Confirms Vance Has Not Yet Departed for Scheduled Iran Talks in Pakistan Is BrightSpring BTSGU stock losing upward momentum 011 20260420 GSIW Garden posts nearly 300 percent Q2 2025 revenue growth shares jump over 9 percent on positive investor reaction MUZE Muzero signals upcoming strategic pivot to niche SaaS markets as quarterly earnings release looms Targa Resources TRGP NRSN NeuroSense Therapeutics Q2 loss narrows 69 more than expected but investors await pipeline catalyst update